Metabolic characterisation of disturbances in the APOC3/triglyceride-rich lipoprotein pathway through sample-based recall by genotype.

Laura J CorbinDavid A HughesAndrew J ChetwyndAmy E TaylorAndrew D SouthamAndris JankevicsRalf J M WeberAlix GroomWarwick B DunnNicholas J Timpson

Published in: Metabolomics : Official journal of the Metabolomic Society (2020)

Overall, our results suggest that therapies targeting apoC-III may potentially achieve a broad shift in lipid profile that favours better metabolic health.

Keyphrases

healthcare
public health
low density lipoprotein
health information
drug delivery
social media
health promotion